CMI
Cummins Inc.
CMI's fundamentals are strong: free cash flow grew 52% and earnings per share grew 23%. At 19x earnings, it's trading in line with its usual 18x. Analysts expect that strong growth to continue.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CMI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
CMI's revenue, profitability, cash flow and balance sheet are all currently healthy.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CMI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $305 | -33% |
| Forward | 14x | $455 | โ |
| Fair | 18x | $423 | -7.2% |
| Current | 19x | $455 | โ |
| Expensive | 25x | $596 | +31% |
Historical ranges are pointers, not guarantees.
CMI's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CMI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CMI, with profitability improving.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CMI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.34 | +35% |
| Q3 2026 | $23.94 | +23% |
| Q2 2026 | $19.55 | -8.9% |
| Q1 2026 | $19.25 | -5.2% |
| Q4 2025 | $20.50 | -28% |
| Q3 2025 | $19.47 | +29% |
| Q2 2025 | $21.47 | +55% |
| Q1 2025 | $20.30 | +49% |
| Q4 2024 | $28.37 | +451% |
CMI has the stronger earnings trend. Trailing diluted EPS is up 23% for CMI versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CMI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.4B | +13% |
| Q2 2026 | $9.5B | +9.4% |
| Q1 2026 | $8.4B | +2.7% |
| Q4 2025 | $8.5B | +1.1% |
| Q3 2025 | $8.3B | -1.6% |
| Q2 2025 | $8.6B | -1.7% |
| Q1 2025 | $8.2B | -2.7% |
| Q4 2024 | $8.4B | -1.1% |
CMI's revenue has grown year over year for four quarters in a row: $9.4B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +5.1 points |
| Q2 2026 | 14% | -0.7 points |
| Q1 2026 | 11% | -2.6 points |
| Q4 2025 | 9.5% | +0.8 points |
| Q3 2025 | 10% | -2.2 points |
| Q2 2025 | 14% | +2.3 points |
| Q1 2025 | 14% | +2.9 points |
| Q4 2024 | 8.7% | +23 points |
CMI has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CMI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was โ96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CMI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +9.4% |
| Q2 2026 | $1.3B | +126% |
| Q1 2026 | $120M | +$285M |
| Q4 2025 | $990M | +12% |
| Q3 2025 | $1B | +164% |
| Q2 2025 | $554M | +$1.6B |
| Q1 2025 | -$165M | -254% |
| Q4 2024 | $882M | -6.2% |
CMI has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: โ$443M over the past year, against โ$246M the year before.
CMI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.1x | Healthy |
CMI's net debt is less than a year of its operating earnings (EBITDA).
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CMI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.0 | Oversold |
| Stochastic | 3.3 | Oversold |
CMI's weekly RSI is 28 (oversold) and its Stochastic is 3 (oversold).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CMI PE vs Industrials Sector
| Metric | CMI | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 24x | 21% below |
| PE % | 58 | 58 | Same percentile |
CMI is trading at 19x earnings, a 21% discount to the Industrials sector's median of 24x.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CMI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $503.9 | 9.6% below |
| 20 week MA | $569.7 | 20% below |
| 50 week MA | $584.4 | 22% below |
| 100 week MA | $475.1 | 4.2% below |
| 200 week MA | $370.2 | 23% above |
CMI has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CMI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $180.7 | $226.5 | +25% |
| 2021 | $226.5 | $214.0 | -5.5% |
| 2022 | $214.0 | $241.3 | +13% |
| 2023 | $241.3 | $239.6 | -0.7% |
| 2024 | $239.6 | $351.2 | +47% |
| 2025 | $351.2 | $519.1 | +48% |
| 2026 YTD | $519.1 | $455.4 | -12% |
CMI has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to โ87% in 2022. It's down 85% so far in 2026.